Risco cardiovascular em mulheres com câncer de mama
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Tipo de documento: | Dissertação |
Idioma: | por |
Título da fonte: | Repositório Institucional da UFG |
dARK ID: | ark:/38995/0013000003f35 |
Texto Completo: | http://repositorio.bc.ufg.br/tede/handle/tede/3370 |
Resumo: | OBJECTIVES: To investigate the prevalence of risk factors for cardiovascular disease (CVD), estimate the cardiovascular risk, acoording to the Framingham and Systematic Coronary Risk Evaluation (SCORE) risk models, and evaluate the agreement between both risk models in middleaged breast cancer survivors (BCS). METHODS: A cross-sectional study was conducted between august 2002 and june 2003, including 67 breast cancer survivors. Participants were recruited from the Menopause and Breast Cancer Outpatient Facilities ( Universidade Estadual de Campinas - UNICAMP), ranging in age from 45 – 65 years, who underwent complete oncologic treatment and were not users of hormone replacement therapy, tamoxifen or aromatase inhibitors in the last six months. Evaluated risk factors for CVD like us: dyslipidemia, obesity, arterial hypertension, diabetes and smoking, and risk of CVD. The risk of CVD was estimated according to the Framingham and SCORE models. The risk of CVD was classified as low ( < 10%) , moderate ( 10 -20%) and high ( > 20%), according to Framingham function, and low ( < 3%), moderate ( ≥ 3% and < 5%) and high ( ≥ 5%), according to SCORE model. A descriptive analysis with absolute and relative frequencies, means and standard deviations (SD) was carried out. To investigate agreement between both risk models, the kappa coefficient was calculated with is respective 95% confidence interval (CI). RESULTS: The mean age of the participants was 53.2± 6.0 years and body mass index (BMI) was 27.8 ± 5.7 Kg/m². Obesity and arterial hypertension occurred in 27% and 34% of participants, respectively. Ninety percent of participants had at least one type of dyslipidemia. The most prevalent dyslipidemias were: high total cholesterol levels (≥ 200 mg/dl) in 70%, high LDL-C (≥ 130 mg/dl) in 51% and high non-HDL-C (≥ 160 mg/dl) in 48% of the participants. The risk of CVD, according to the Framingham model, was classified as low (45%), moderate (33%) and high (22%); and low (96%) and moderate (4%) according to the SCORE equation. The agreement between Framingham and SCORE models was poor (kappa coefficient of 0.122 with 95% CI: 0.013 to 0.231). CONCLUSIONS: The prevalence of risk factors for cardiovascular disease was high. Dyslipidemia was common in this cohort. The majority of participants had low to moderate cardiovascular risk. The agreement between both risk models was poor. These data indicate that the prevention of CVD in middle-aged breast cancer survivors is necessary and close attention should be focused on adequate control of serum lipid levels. KEYWORDS: breast cancer, dyslipidemia, disease cardiovascular, score of cardiovascular risk. |
id |
UFG-2_3c520c629ea6d5170feaf6c7726edc3c |
---|---|
oai_identifier_str |
oai:repositorio.bc.ufg.br:tede/3370 |
network_acronym_str |
UFG-2 |
network_name_str |
Repositório Institucional da UFG |
repository_id_str |
|
spelling |
Conde, Délio Marqueshttp://lattes.cnpq.br/8628571386803692Conde, Délio MarquesAmaral, Waldemar Naves doAmaral, Rita GoretiFerreira, Rui Gilbertohttp://lattes.cnpq.br/9390506247078350Silva, Érika Pereira de Sousa e2014-10-17T20:40:14Z2013-12-12SILVA, Érika Pereira de Sousa e. Risco cardiovascular em mulheres com câncer de mama. 2013. 113 f. Dissertação (Mestrado em Ciências da Saúde) - Universidade Federal de Goiás, Goiânia, 2013.http://repositorio.bc.ufg.br/tede/handle/tede/3370ark:/38995/0013000003f35OBJECTIVES: To investigate the prevalence of risk factors for cardiovascular disease (CVD), estimate the cardiovascular risk, acoording to the Framingham and Systematic Coronary Risk Evaluation (SCORE) risk models, and evaluate the agreement between both risk models in middleaged breast cancer survivors (BCS). METHODS: A cross-sectional study was conducted between august 2002 and june 2003, including 67 breast cancer survivors. Participants were recruited from the Menopause and Breast Cancer Outpatient Facilities ( Universidade Estadual de Campinas - UNICAMP), ranging in age from 45 – 65 years, who underwent complete oncologic treatment and were not users of hormone replacement therapy, tamoxifen or aromatase inhibitors in the last six months. Evaluated risk factors for CVD like us: dyslipidemia, obesity, arterial hypertension, diabetes and smoking, and risk of CVD. The risk of CVD was estimated according to the Framingham and SCORE models. The risk of CVD was classified as low ( < 10%) , moderate ( 10 -20%) and high ( > 20%), according to Framingham function, and low ( < 3%), moderate ( ≥ 3% and < 5%) and high ( ≥ 5%), according to SCORE model. A descriptive analysis with absolute and relative frequencies, means and standard deviations (SD) was carried out. To investigate agreement between both risk models, the kappa coefficient was calculated with is respective 95% confidence interval (CI). RESULTS: The mean age of the participants was 53.2± 6.0 years and body mass index (BMI) was 27.8 ± 5.7 Kg/m². Obesity and arterial hypertension occurred in 27% and 34% of participants, respectively. Ninety percent of participants had at least one type of dyslipidemia. The most prevalent dyslipidemias were: high total cholesterol levels (≥ 200 mg/dl) in 70%, high LDL-C (≥ 130 mg/dl) in 51% and high non-HDL-C (≥ 160 mg/dl) in 48% of the participants. The risk of CVD, according to the Framingham model, was classified as low (45%), moderate (33%) and high (22%); and low (96%) and moderate (4%) according to the SCORE equation. The agreement between Framingham and SCORE models was poor (kappa coefficient of 0.122 with 95% CI: 0.013 to 0.231). CONCLUSIONS: The prevalence of risk factors for cardiovascular disease was high. Dyslipidemia was common in this cohort. The majority of participants had low to moderate cardiovascular risk. The agreement between both risk models was poor. These data indicate that the prevention of CVD in middle-aged breast cancer survivors is necessary and close attention should be focused on adequate control of serum lipid levels. KEYWORDS: breast cancer, dyslipidemia, disease cardiovascular, score of cardiovascular risk.OBJETIVOS: Investigar a prevalência de fatores de risco de doença cardiovascular (DCV), estimar o risco cardiovascular de acordo com os modelos de Framingham e Systematic Coronary Risk Evaluation (SCORE), e avaliar a concordância entre esses dois modelos de risco em mulheres de meia-idade com câncer de mama. METODOLOGIA: Conduziu-se estudo de corte transversal entre agosto de 2002 a julho de 2003, incluindo 67 mulheres do Ambulatório de Menopausa e Ambulatório de Oncologia Mamária da Universidade Estadual de Campinas (UNICAMP), com idade entre 45-65 anos, não usuárias de terapia hormonal, tamoxifeno ou inibidores de aromatase nos últimos seis meses. Avaliou-se a prevalência de fatores de risco cardiovascular tais como: dislipidemia, diabetes, obesidade, tabagismo e hipertensão arterial e o risco de DCV. O risco de DCV foi calculado de acordo com os modelos de Framingham e SCORE. O risco de DCV foi classificado em baixo (<10%), moderado (10-20%) e alto (>20%) de acordo com a função de Framingham, e em baixo (< 3%), moderado (≥3% e < 5%) e alto (≥ 5%), segundo o modelo SCORE. Realizou-se análise descritiva dos dados com cálculo das frequências absoluta e relativa, média e desvio padrão. Para investigar a concordância entre os dois modelos de risco cadiovascular calculou-se o coeficiente kappa (k) com seu respectivo intervalo de confiança (IC) de 95%. RESULTADOS: A média de idade das participantes foi de 53,2±6,04 anos e do índice de massa corpórea (IMC) de 27,8±5,7Kg/m². A prevalência de obesidade e hipertensão foi 27% e 34%, respectivamente. Noventa porcento das participantesapresentaram pelo menos um tipo de dislipidemia. As anormalidades mais frequentes no perfil lipídico foram: colesterol total elevado (≥200 mg/dL) em 70%, alto LDL-C (≥ 130 mg/dL) em 51% e alto não-HDL-C ( (≥ 160mg/dL) em 48% das participantes. O risco de DCV, segundo o modelo de Framingham, foi classificado como baixo (45%), moderado (33%) e alto (22%), e, segundo a equação SCORE, como baixo (96%) e moderado (4%). A concordância entre os modelos Framingham e SCORE foi ruim ( kappa: 0,122; IC 95%: 0,013-0,231), considerando populações de alto risco de DCV. CONCLUSÕES: A prevalência de fatores de risco de DCV foi elevada. Dislipidemia foi comum nessa coorte. A maior parte das participantes apresentou risco baixo a moderado de DCV. A concordância entre os dois modelos de risco foi ruim. Esses dados indicam a necessidade de incluir na rotina de seguimento de mulheres com câncer de mama a avaliação do perfil lipídico e do risco de DCV, atentando-se para o adequado controle dos níveis séricos de lipídios. PALAVRAS-CHAVES: câncer de mama, dislipidemia, doença cardiovascular, modelos de risco cardiovascular.Submitted by Cássia Santos (cassia.bcufg@gmail.com) on 2014-10-14T12:13:52Z No. of bitstreams: 2 Dissertacao - Erika Pereira de Sousa e Silva - Ciencias da Saude.pdf: 2543710 bytes, checksum: b2724690edf58def58456f7de1f5455d (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)Approved for entry into archive by Jaqueline Silva (jtas29@gmail.com) on 2014-10-17T20:40:14Z (GMT) No. of bitstreams: 2 Dissertacao - Erika Pereira de Sousa e Silva - Ciencias da Saude.pdf: 2543710 bytes, checksum: b2724690edf58def58456f7de1f5455d (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)Made available in DSpace on 2014-10-17T20:40:14Z (GMT). No. of bitstreams: 2 Dissertacao - Erika Pereira de Sousa e Silva - Ciencias da Saude.pdf: 2543710 bytes, checksum: b2724690edf58def58456f7de1f5455d (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2013-12-12application/pdfhttp://repositorio.bc.ufg.br/tede/retrieve/10675/Dissertacao%20-%20Erika%20Pereira%20de%20Sousa%20e%20Silva%20-%20Ciencias%20da%20Saude.pdf.jpgporUniversidade Federal de GoiásPrograma de Pós-graduação em Ciências da Saúde (FM)UFGBrasilFaculdade de Medicina - FM (RG)http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessCâncer de mamaRisco cardiovascularDislipidemiaModelos de risco cardiovascularBreast cancerCardiovascular riskDyslipidemiaScore cardiovascular riskCIENCIAS DA SAUDE::MEDICINARisco cardiovascular em mulheres com câncer de mamaCardiovascular risk of women with breast cancerinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis-10068643126177453106006006001545772475950486338-969369452308786627reponame:Repositório Institucional da UFGinstname:Universidade Federal de Goiás (UFG)instacron:UFGLICENSElicense.txtlicense.txttext/plain; charset=utf-82165http://repositorio.bc.ufg.br/tede/bitstreams/c5bff409-95bd-46c7-807b-e630e6dcd97d/downloadbd3efa91386c1718a7f26a329fdcb468MD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849http://repositorio.bc.ufg.br/tede/bitstreams/3d8acb07-50bb-48ce-8706-0d8723248d63/download4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-822302http://repositorio.bc.ufg.br/tede/bitstreams/381ef1b2-4b66-4107-af4d-2ac55b6af55b/download1e0094e9d8adcf16b18effef4ce7ed83MD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-823148http://repositorio.bc.ufg.br/tede/bitstreams/256547e5-118b-4cca-8306-b2bea8add41a/download9da0b6dfac957114c6a7714714b86306MD54ORIGINALDissertacao - Erika Pereira de Sousa e Silva - Ciencias da Saude.pdfDissertacao - Erika Pereira de Sousa e Silva - Ciencias da Saude.pdfapplication/pdf2543710http://repositorio.bc.ufg.br/tede/bitstreams/62d10e5b-1362-4e77-8953-ac81fb547f79/downloadb2724690edf58def58456f7de1f5455dMD55TEXTDissertacao - Erika Pereira de Sousa e Silva - Ciencias da Saude.pdf.txtDissertacao - Erika Pereira de Sousa e Silva - Ciencias da Saude.pdf.txtExtracted Texttext/plain139889http://repositorio.bc.ufg.br/tede/bitstreams/3b88296e-898e-438b-8304-ea06d9f40f4f/downloadc793f576c2e07d59b3b2f0793a592b43MD56THUMBNAILDissertacao - Erika Pereira de Sousa e Silva - Ciencias da Saude.pdf.jpgDissertacao - Erika Pereira de Sousa e Silva - Ciencias da Saude.pdf.jpgGenerated Thumbnailimage/jpeg3573http://repositorio.bc.ufg.br/tede/bitstreams/920ffea6-94c4-4cb0-8acc-2664232391ba/download9c2a353a1b868d6a7a035f0e5ec28a36MD57tede/33702014-10-22 03:02:26.828http://creativecommons.org/licenses/by-nc-nd/4.0/Acesso Abertoopen.accessoai:repositorio.bc.ufg.br:tede/3370http://repositorio.bc.ufg.br/tedeRepositório InstitucionalPUBhttp://repositorio.bc.ufg.br/oai/requesttasesdissertacoes.bc@ufg.bropendoar:2014-10-22T05:02:26Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)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 |
dc.title.por.fl_str_mv |
Risco cardiovascular em mulheres com câncer de mama |
dc.title.alternative.eng.fl_str_mv |
Cardiovascular risk of women with breast cancer |
title |
Risco cardiovascular em mulheres com câncer de mama |
spellingShingle |
Risco cardiovascular em mulheres com câncer de mama Silva, Érika Pereira de Sousa e Câncer de mama Risco cardiovascular Dislipidemia Modelos de risco cardiovascular Breast cancer Cardiovascular risk Dyslipidemia Score cardiovascular risk CIENCIAS DA SAUDE::MEDICINA |
title_short |
Risco cardiovascular em mulheres com câncer de mama |
title_full |
Risco cardiovascular em mulheres com câncer de mama |
title_fullStr |
Risco cardiovascular em mulheres com câncer de mama |
title_full_unstemmed |
Risco cardiovascular em mulheres com câncer de mama |
title_sort |
Risco cardiovascular em mulheres com câncer de mama |
author |
Silva, Érika Pereira de Sousa e |
author_facet |
Silva, Érika Pereira de Sousa e |
author_role |
author |
dc.contributor.advisor1.fl_str_mv |
Conde, Délio Marques |
dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/8628571386803692 |
dc.contributor.referee1.fl_str_mv |
Conde, Délio Marques |
dc.contributor.referee2.fl_str_mv |
Amaral, Waldemar Naves do |
dc.contributor.referee3.fl_str_mv |
Amaral, Rita Goreti |
dc.contributor.referee4.fl_str_mv |
Ferreira, Rui Gilberto |
dc.contributor.authorLattes.fl_str_mv |
http://lattes.cnpq.br/9390506247078350 |
dc.contributor.author.fl_str_mv |
Silva, Érika Pereira de Sousa e |
contributor_str_mv |
Conde, Délio Marques Conde, Délio Marques Amaral, Waldemar Naves do Amaral, Rita Goreti Ferreira, Rui Gilberto |
dc.subject.por.fl_str_mv |
Câncer de mama Risco cardiovascular Dislipidemia Modelos de risco cardiovascular |
topic |
Câncer de mama Risco cardiovascular Dislipidemia Modelos de risco cardiovascular Breast cancer Cardiovascular risk Dyslipidemia Score cardiovascular risk CIENCIAS DA SAUDE::MEDICINA |
dc.subject.eng.fl_str_mv |
Breast cancer Cardiovascular risk Dyslipidemia Score cardiovascular risk |
dc.subject.cnpq.fl_str_mv |
CIENCIAS DA SAUDE::MEDICINA |
description |
OBJECTIVES: To investigate the prevalence of risk factors for cardiovascular disease (CVD), estimate the cardiovascular risk, acoording to the Framingham and Systematic Coronary Risk Evaluation (SCORE) risk models, and evaluate the agreement between both risk models in middleaged breast cancer survivors (BCS). METHODS: A cross-sectional study was conducted between august 2002 and june 2003, including 67 breast cancer survivors. Participants were recruited from the Menopause and Breast Cancer Outpatient Facilities ( Universidade Estadual de Campinas - UNICAMP), ranging in age from 45 – 65 years, who underwent complete oncologic treatment and were not users of hormone replacement therapy, tamoxifen or aromatase inhibitors in the last six months. Evaluated risk factors for CVD like us: dyslipidemia, obesity, arterial hypertension, diabetes and smoking, and risk of CVD. The risk of CVD was estimated according to the Framingham and SCORE models. The risk of CVD was classified as low ( < 10%) , moderate ( 10 -20%) and high ( > 20%), according to Framingham function, and low ( < 3%), moderate ( ≥ 3% and < 5%) and high ( ≥ 5%), according to SCORE model. A descriptive analysis with absolute and relative frequencies, means and standard deviations (SD) was carried out. To investigate agreement between both risk models, the kappa coefficient was calculated with is respective 95% confidence interval (CI). RESULTS: The mean age of the participants was 53.2± 6.0 years and body mass index (BMI) was 27.8 ± 5.7 Kg/m². Obesity and arterial hypertension occurred in 27% and 34% of participants, respectively. Ninety percent of participants had at least one type of dyslipidemia. The most prevalent dyslipidemias were: high total cholesterol levels (≥ 200 mg/dl) in 70%, high LDL-C (≥ 130 mg/dl) in 51% and high non-HDL-C (≥ 160 mg/dl) in 48% of the participants. The risk of CVD, according to the Framingham model, was classified as low (45%), moderate (33%) and high (22%); and low (96%) and moderate (4%) according to the SCORE equation. The agreement between Framingham and SCORE models was poor (kappa coefficient of 0.122 with 95% CI: 0.013 to 0.231). CONCLUSIONS: The prevalence of risk factors for cardiovascular disease was high. Dyslipidemia was common in this cohort. The majority of participants had low to moderate cardiovascular risk. The agreement between both risk models was poor. These data indicate that the prevention of CVD in middle-aged breast cancer survivors is necessary and close attention should be focused on adequate control of serum lipid levels. KEYWORDS: breast cancer, dyslipidemia, disease cardiovascular, score of cardiovascular risk. |
publishDate |
2013 |
dc.date.issued.fl_str_mv |
2013-12-12 |
dc.date.accessioned.fl_str_mv |
2014-10-17T20:40:14Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
SILVA, Érika Pereira de Sousa e. Risco cardiovascular em mulheres com câncer de mama. 2013. 113 f. Dissertação (Mestrado em Ciências da Saúde) - Universidade Federal de Goiás, Goiânia, 2013. |
dc.identifier.uri.fl_str_mv |
http://repositorio.bc.ufg.br/tede/handle/tede/3370 |
dc.identifier.dark.fl_str_mv |
ark:/38995/0013000003f35 |
identifier_str_mv |
SILVA, Érika Pereira de Sousa e. Risco cardiovascular em mulheres com câncer de mama. 2013. 113 f. Dissertação (Mestrado em Ciências da Saúde) - Universidade Federal de Goiás, Goiânia, 2013. ark:/38995/0013000003f35 |
url |
http://repositorio.bc.ufg.br/tede/handle/tede/3370 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.program.fl_str_mv |
-1006864312617745310 |
dc.relation.confidence.fl_str_mv |
600 600 600 |
dc.relation.department.fl_str_mv |
1545772475950486338 |
dc.relation.cnpq.fl_str_mv |
-969369452308786627 |
dc.rights.driver.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Goiás |
dc.publisher.program.fl_str_mv |
Programa de Pós-graduação em Ciências da Saúde (FM) |
dc.publisher.initials.fl_str_mv |
UFG |
dc.publisher.country.fl_str_mv |
Brasil |
dc.publisher.department.fl_str_mv |
Faculdade de Medicina - FM (RG) |
publisher.none.fl_str_mv |
Universidade Federal de Goiás |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFG instname:Universidade Federal de Goiás (UFG) instacron:UFG |
instname_str |
Universidade Federal de Goiás (UFG) |
instacron_str |
UFG |
institution |
UFG |
reponame_str |
Repositório Institucional da UFG |
collection |
Repositório Institucional da UFG |
bitstream.url.fl_str_mv |
http://repositorio.bc.ufg.br/tede/bitstreams/c5bff409-95bd-46c7-807b-e630e6dcd97d/download http://repositorio.bc.ufg.br/tede/bitstreams/3d8acb07-50bb-48ce-8706-0d8723248d63/download http://repositorio.bc.ufg.br/tede/bitstreams/381ef1b2-4b66-4107-af4d-2ac55b6af55b/download http://repositorio.bc.ufg.br/tede/bitstreams/256547e5-118b-4cca-8306-b2bea8add41a/download http://repositorio.bc.ufg.br/tede/bitstreams/62d10e5b-1362-4e77-8953-ac81fb547f79/download http://repositorio.bc.ufg.br/tede/bitstreams/3b88296e-898e-438b-8304-ea06d9f40f4f/download http://repositorio.bc.ufg.br/tede/bitstreams/920ffea6-94c4-4cb0-8acc-2664232391ba/download |
bitstream.checksum.fl_str_mv |
bd3efa91386c1718a7f26a329fdcb468 4afdbb8c545fd630ea7db775da747b2f 1e0094e9d8adcf16b18effef4ce7ed83 9da0b6dfac957114c6a7714714b86306 b2724690edf58def58456f7de1f5455d c793f576c2e07d59b3b2f0793a592b43 9c2a353a1b868d6a7a035f0e5ec28a36 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFG - Universidade Federal de Goiás (UFG) |
repository.mail.fl_str_mv |
tasesdissertacoes.bc@ufg.br |
_version_ |
1815172545786150912 |